Sabine Kayser

7PUBLICATIONS
8CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 06, 2026
Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy.

Stefan Markus Dendorfer, Katharina Schmidt-Brücken, Michael Kramer

|Apr 27, 2024
Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations.

Philipp Blüm, Sabine Kayser

|Aug 17, 2021
Two rare cases of bronchus-associated lymphoid tissue lymphoma successfully treated with rituximab-bendamustine.

Nydia Panitz, Kristin Gerhardt, Cornelia Becker

|Aug 05, 2021
Updates on targeted therapies for acute myeloid leukaemia.

Sabine Kayser, Mark J Levis

|Feb 02, 2021
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.

Sabine Kayser, Robert K Hills, Ralitsa Langova

|Sep 12, 2018
Clinical implications of molecular markers in acute myeloid leukemia.

Sabine Kayser, Mark J Levis

Pageof 2

Frequent Collaborators

2 joint publications

Mark J Levis

1 joint publications

Robert K Hills

1 joint publications

Zdeněk Ráčil

1 joint publications

Roland B Walter